RESULTS OF GENEXPERT EXAMINATION IN PATIENTS SUSPECTED OF TUBERCULOSIS AT DR. SOEPRAOEN ARMY HOSPITAL IN 2023
Abstract
Pulmonary tuberculosis is an infectious disease that continues to be a major public health problem worldwide. It is caused by Mycobacterium tuberculosis infection and remains the second leading cause of death from infectious diseases globally. According to the 2023 report from the Malang City Health Office, there were 17,010 suspected tuberculosis cases. Confirmed cases included 565 cases identified at primary health centers, 1,632 at hospitals, and 19 in correctional facilities. This study aimed to describe the GeneXpert examination results among suspected tuberculosis cases at Dr. Soepraoen Army Hospital (RST TK II Dr, Soepraoen), Malang. The study employed a descriptive cross-sectional design using the total sampling method. A total of 2,944 samples were examined. The findings showed that GeneXpert examinations were most frequently conducted among young adults (20–44 years), followed by middle adults (45–64 years). Based on gender, men constituted the majority, accounting for 58% of the study population, while women made up 42% of the cases. Regarding patients’ location of residence, Sukun District in Malang City had the highest number of patients who tested positive for tuberculosis by the GeneXpert examination. Overall, positive GeneXpert were most frequently observed among young adult and middle-age adults. In addition, the number of men with positive results was higher than that of women. Sukun District recorded the highest number of positive GeneXpert results at RST TK II Dr. Soepraoen.
Keywords: GeneXpert, Mycobacterium tuberculosis, molecular rapid test, pulmonary tuberculosis
References
2. World Health Organization. Tuberculosis: Fact Sheet. Geneva: WHO; 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/tuberculosis. Accessed 28 Jan 2026.
3. Ministry of Health of the Republic of Indonesia. National Tuberculosis Control Strategy 2020–2024. Jakarta: Ministry of Health; 2020.
4. Ministry of Health of the Republic of Indonesia. National Guidelines for Tuberculosis Control. Jakarta: Ministry of Health; 2020.
5. Directorate General of P2P, Ministry of Health, Republic of Indonesia. National TB Program Progress Report. Jakarta: Ministry of Health; 2021.
6. Malang City Health Office. Malang City Health Profile 2022. Malang: Dinkes Kota Malang; 2023.
7. Malang Regency Health Office. Malang Regency Health Profile 2022. Malang: Dinkes Kabupaten Malang; 2023.
8. Shah AR, Desai KN, Maru AM. Evaluation of hematological parameters in pulmonary tuberculosis patients. J Fam Med Prim Care. 2022;11(8):4424–4428. doi:10.4103/jfmpc.jfmpc_2451_21.
9. Liu HC, Gao YL, Li DF, Zhao XY, Pan YQ, Zhu CT. Value of Xpert MTB/RIF using bronchoalveolar lavage fluid for diagnosis of pulmonary tuberculosis: systematic review and meta-analysis. J Clin Microbiol. 2021;59(4):e02170-20. doi:10.1128/JCM.02170-20.
10. World Health Organization. Consolidated Guidelines on Tuberculosis: Module 3 – Rapid Diagnostics for TB Detection. Geneva: WHO; 2021. Available from: https://www.who.int/publications/i/item/9789240037021. Accessed 28 Jan 2026.
11. Cepheid. Xpert MTB/RIF Ultra Package Insert. Sunnyvale: Cepheid; 2021.
12. Cepheid. Xpert MTB/RIF Package Insert. Sunnyvale: Cepheid; 2021.
13. Phetsuksiri B, Klayut W, Rudeeaneksin J, Srisungngam S, Bunchoo S, Toonkomdang S, et al. The performance of an in-house loop-mediated isothermal amplification for the rapid detection of Mycobacterium tuberculosis in sputum samples in comparison with Xpert MTB/RIF, microscopy and culture. Rev Inst Med Trop Sao Paulo. 2020;62:e36. doi:10.1590/S1678-9946202062036.
14. Sunarmi S, Kurniawaty K. The relationship between characteristics of pulmonary TB patients and the incidence of TB. J Aisyiyah Med. 2022;7(2):182–187.
15. Salsabila LZ, Putri AY, Fauzi R, et al. Analysis of factors of OAT compliance in pulmonary TB patients. J Public Health Res. 2021;10(1):2141. doi:10.4081/jphr.2021.2141.
16. Muñoz L, Moure R, Porta N, et al. GeneXpert for smear-negative pulmonary tuberculosis in low-burden countries. Diagn Microbiol Infect Dis. 2018;90(2):96–100. doi:10.1016/j.diagmicrobio.2017.10.010.
17. Gupta RK, Lucas SB, Fielding KL, Lawn SD. Risk factors associated with tuberculosis: systematic review. Lancet Infect Dis. 2020;20(3):e34–e46. doi:10.1016/S1473-3099(19)30553-3.
18. Karmakar M, Brahma S, Dutta R, et al. Determinants of TB transmission in urban areas: a cross-sectional study. BMC Public Health. 2021;21:574. doi:10.1186/s12889-021-10568-8.
19. Wang L, Liu J, Chin DP. Socioeconomic factors influencing pulmonary TB: a multi-country analysis. Int J Infect Dis. 2021;103:S89–S97. doi:10.1016/j.ijid.2020.12.024.
20. Rahman A, Majumder MA, Azad AK. Association between smoking and pulmonary TB: findings from a national health survey. BMJ Open. 2020;10(7):e035827. doi:10.1136/bmjopen-2019-035827.
21. Silva DR, Menegotto DM, Schulz LF, et al. Comorbidities and TB outcomes: a retrospective analysis. Chest. 2018;154(2):275–283. doi:10.1016/j.chest.2018.04.013.
22. Ade S, Corbett EL, Johnston JC, et al. Gender differences in TB incidence and health-seeking behavior: a multi-site analysis. Public Health Action. 2019;9(4):134–141. doi:10.5588/pha.19.0026
23. Chatterjee P, Dutta S, Banerjee A, et al. Crowding, hygiene, and TB transmission risks: evidence from urban settlements. Trop Med Int
